Approvals/TGA/APOTEX-DROSPIRENONE/EE 3/30 drospirenone 3 mg and ethinylestradiol 30 microgram film-coated tablet blister pack

Approved

STANDARD

APOTEX-DROSPIRENONE/EE 3/30 drospirenone 3 mg and ethinylestradiol 30 microgram film-coated tablet blister pack

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7bdfbca19f016331
Product Name: APOTEX-DROSPIRENONE/EE 3/30 drospirenone 3 mg and ethinylestradiol 30 microgram film-coated tablet blister pack
Artg Id: 195218
Artg Name: APOTEX-DROSPIRENONE/EE 3/30 drospirenone 3 mg and ethinylestradiol 30 microgram film-coated tablet blister pack
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2013-05-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7bdfbca19f016331

Type

Standard